Targeted MRI–transrectal ultrasonography (MRI–TRUS) fusion biopsy is emerging as a powerful new technique to more accurately diagnose clinically significant prostate cancer. A recent study comparing ...

Although easily performed in an office based setting with a side effect profile similar to standard TRUS bx, [10,11] routine AZ sampling during saturation biopsy does not appear to offer a significant ...

Early diagnosis of prostate cancer, AABH (Aspartyl Asparaginyl β-hydroxylase), a predictive biomarker: A serum immunoassay and personalized medicine. This is an ASCO Meeting Abstract from the 2020 ...

COPENHAGEN, Denmark — The standard of care for diagnosing prostate cancer is set to change because of results now published from a head-to-head comparison of two different approaches. The study, known ...

Results from the phase 3 PRECISE trial showed that MRI with targeted biopsies matched or exceeded the accuracy of the current standard for detecting clinically significant prostate cancer. The current ...

Local anesthetic transperineal (LATP) biopsy for prostate cancer detection is gaining in popularity due to concerns about infectious complications with transrectal ultrasound (TRUS) biopsy. LATP ...

Prostate cancer is screened for by digital rectal examination and by measuring serum prostate-specific antigen (PSA) levels. If these arouse any suspicion of prostate cancer, a prostate biopsy is ...

A transrectal ultrasound-guided prostate biopsy is a surgical procedure used to obtain tissue cores in order to diagnose or exclude the presence of cancer. As such, the technique carries its own risks ...

Adding shear wave elastography, which measures tissue stiffness, to conventional TRUS-guided prostate biopsy may aid detection of prostate cancer. Adding shear wave elastography (SWE) to transrectal ...

Biopsy with local anesthetic ultrasound-guided transperineal (LATP) identified more clinically significant prostate cancers than transrectal ultrasound (TRUS), but the procedure came with tradeoffs, a ...